Results 161 to 170 of about 939 (187)
Some of the next articles are maybe not open access.

Ubrogepant for the Treatment of Migraine Attacks During the Prodrome: A Phase 3, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Trial in the USA

Lancet, The, 2023
Todd J. Schwedt   +2 more
exaly  

Real World Efficacy, Tolerability and Safety of Ubrogepant (2485)

Neurology, 2021
Chia-Chun Chiang   +6 more
openaire   +1 more source

Evaluation of the Pharmacokinetic Interaction and Safety of Ubrogepant Coadministered With Esomeprazole Magnesium

Clinical Pharmacology in Drug Development, 2022
Ramesh R Boinpally
exaly  

Ubrogepant zur Behandlung akuter Migräneattacken

Schmerzmedizin, 2021
openaire   +1 more source

Phase Ib, Open-Label, Fixed-Sequence, Drug–Drug Interaction, Safety, and Tolerability Study Between Atogepant and Ubrogepant in Participants With a History of Migraine

Headache, 2023
Jessica Ailani   +2 more
exaly  

Safety and Efficacy of Ubrogepant for the Acute Treatment of Perimenstrual Migraine Attacks: A Post Hoc Analysis

Headache, 2023
Susan Hutchinson   +2 more
exaly  

Pharmacokinetics and Safety of Ubrogepant When Coadministered With Calcitonin Gene‒Related Peptide-Targeted Monoclonal Antibody Migraine Preventives in Participants With Migraine: A Randomized Phase 1b Drug–Drug Interaction Study

Headache, 2021
Richard B. Lipton   +2 more
exaly  

Synthesis of Ubrogepant

Synfacts, 2018
openaire   +1 more source

Single-Dose Pharmacokinetics and Safety of Ubrogepant in Adults With Hepatic Impairment: Results From an Open-Label, Phase 1 Trial

Clinical Pharmacology in Drug Development, 2022
Ramesh R Boinpally
exaly  

Pain Freedom at 2 to 8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant

Headache: The Journal of Head and Face Pain, 2020
Erin G, Doty   +5 more
openaire   +2 more sources
migraine
pyridines
pyrroles
humans
3. good health
migraine disorders
adult
cgrp
gepants
previous   15  16  17  18  19  

Home - About - Disclaimer - Privacy